Goss Wealth Management »

Emergent BioSolutions shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.6k 586 9.56
2022-12-31 $1.6k 135 11.81

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Ishares Core MF Closed and MF Open (IVV)
SPDR S&P MF Closed and MF Open (SPY)
Vanguard S&p MF Closed and MF Open (VOO)
Broadcom Common Stock (AVGO)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Ishares U S MF Closed and MF Open (DYNF)
Ishares Msci MF Closed and MF Open (QUAL)
Ishares S&p MF Closed and MF Open (IVW)
Vanguard Value MF Closed and MF Open (VTV)
Vanguard Growth MF Closed and MF Open (VUG)
Meta Platforms Common Stock (META)

View all positions for Goss Wealth Management

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Palisade Capital Management
Charles Schwab Investment Management
Geode Capital Management
Acadian Asset Management
Connor, Clark & Lunn Investment Management
Marshall Wace
LSV Asset Management
Prescott Group Capital Management
Morgan Stanley

View all funds holding Emergent BioSolutions